Source-backed study context

Peptide study discovery

A compact directory for locating published study design, population, source, and registry context. It is not a study-results database, a clinical guideline, or a treatment tool.

03

Curated records

4

Source links

01

Registry-linked record

Showing 3 of 3 curated source records. Filters run in the browser and do not collect search terms.

CJC-1295 · 2006

CJC-1295 randomized controlled study record

Journal of Clinical Endocrinology & Metabolism

Design

Two randomized, placebo-controlled, double-blind ascending-dose studies

Population

Healthy adults ages 21–61

Record scope

Short-duration biomarker and pharmacokinetic context involving GH and IGF-1 measures.

Limit: This record describes the published study context only. It does not establish individual benefit, safety, suitability, or a use recommendation.

Tesamorelin · 2014

Tesamorelin randomized clinical trial record

JAMA

Design

Randomized clinical trial

Population

A defined HIV-infected population with abdominal fat accumulation

Record scope

Population-specific trial context recorded in the publication source.

Limit: A population-specific study should not be generalized to other people, products, contexts, or treatment decisions.

Retatrutide · 2023

Retatrutide phase 2 study record

New England Journal of Medicine

Design

Phase 2, double-blind, randomized, placebo-controlled trial

Population

Adults with obesity or overweight plus a weight-related condition

Record scope

Published trial-design, population, and registry context.

Limit: This directory does not summarize dosing, make treatment claims, or establish product-level availability or suitability.

🔗 More tools, guides, vendor links, and resources below ↓